BCL11A and neoplasm: Along with other key epigenomic drivers of nephrogenesis, including other SWI/SNF complex constituents or downstream PRC2 complex components, BCL11A appears to play a role in the differentiation program of nephron progenitor cells, further supporting its potential as a tumor suppressor candidate (16).